학술논문
Paclitaxel plus carboplatin and durvalumab with or without oleclumab for women with previously untreated locally advanced or metastatic triple-negative breast cancer: the randomized SYNERGY phase I/II trial
Document Type
Article
Author
Buisseret, L.; Aftimos, P.; Debien, V.; Kristanto, P.; Eiger, D.; Denis, Z.; Agostinetto, E.; de Azambuja, E.; Rothé, F.; Craciun, L.; Venet, D.; Paesmans, M.; Larsimont, D.; Sotiriou, C.; Ignatiadis, M.; Piccart-Gebhart, M.; Loirat, D.; Maurer, C.; Punie, K.; Goncalves, A.; Ghiringhelli, F.; Taylor, D.; Clatot, F.; Van den Mooter, T.; Ferrero, J.-M.; Bonnefoi, H.; Canon, J.-L.; Duhoux, F.P.; Mansi, L.; Poncin, R.; Barthélémy, P.; Isambert, N.; Catteau, X.; Salgado, R.; Romano, E.; Stagg, J.
Source
In: Nature Communications . (Nature Communications, December 2023, 14(1))
Subject
Language
English
ISSN
20411723